Updated July 2026 · 8 min read

Methylene Blue: The ICU Nurse's Guide

Part of the ICU Emergencies Hub — browse every related guide in one place.

Methylene blue is the dye that doubles as a rescue drug for vasoplegic shock — the profound vasodilation that sometimes follows cardiac surgery, sepsis, or anaphylaxis and refuses to respond to pressors. It works upstream of the vessels, on the nitric-oxide signaling that is driving them open. It also turns urine green and confuses the pulse oximeter, so know what you are looking at. Here is the picture.

How methylene blue works

Vasoplegia is driven by excess nitric oxide, which activates guanylate cyclase to make cyclic GMP, which relaxes vascular smooth muscle — vessels stay wide open and no amount of catecholamine seems to close them. Methylene blue interrupts this chain: it inhibits nitric oxide synthase and, importantly, guanylate cyclase, lowering cGMP and restoring vascular tone. Because it acts on the signaling that is causing the dilation rather than pushing harder on adrenergic receptors, it can work where more pressor cannot.

Dosing

Methylene blue is given as a slow bolus, sometimes followed by an infusion, with continuous hemodynamic monitoring. Effects on blood pressure can be seen fairly quickly in a truly vasoplegic patient. It is a rescue therapy layered onto the standard shock management, not a first-line pressor.

The cautions that catch nurses off guard

Falsely low SpO2. The blue dye absorbs light at the wavelengths the pulse oximeter uses, transiently dropping the displayed SpO2 even when true oxygenation is fine. Don't chase a sudden pulse-ox drop right after a dose — correlate with a blood gas.

Blue-green urine (and sometimes skin/secretions). Harmless and expected, but reassure the patient and team so no one mistakes it for a new problem.

Where it fits

Its best-defined role is post-cardiopulmonary-bypass vasoplegia, where the syndrome is common and methylene blue is an established rescue. It is also used in refractory septic shock and in anaphylaxis unresponsive to standard therapy, and — at different dosing — as the treatment for acquired methemoglobinemia. In the shock context, think of it alongside angiotensin II and vasopressin as a non-catecholamine option when the vessels won't respond.

Why CRNA students should know it

On the CRNA path, methylene blue is a cardiac-anesthesia staple for post-bypass vasoplegia, and it is a favorite exam topic because of the serotonin-syndrome interaction and the pulse-oximetry artifact. Understanding the nitric-oxide/cGMP mechanism connects vasoplegia physiology to a targeted treatment — exactly the kind of reasoning anesthesia builds on.

Bottom line

Methylene blue is the nitric-oxide-pathway rescue for refractory vasoplegia: it restores vascular tone where pressors alone can't, most clearly after cardiac bypass. Screen for serotonergic drugs and G6PD deficiency, expect the green urine and the false SpO2 dip, and give it slowly. Learn its mechanism and its traps now — you will meet it again in the OR.

This article is general educational information for licensed clinicians and students, not medical advice or a substitute for your institution's protocols, pharmacy guidance, or a provider's orders. Always follow facility policy and verify every dose independently.